Indian HIV Diagnostic Market Expected to Grow Exponentially |
Although elisa based tests currently dominate this market, the popularity of rapid tests as a result of their ease of use and faster results is increasing rapidly in the country. |
|
|
  |
|
Contact Information |
|
Krishna sharma
sec-10, Noida
Noida
U.P - 201301
India
911204256531
press@syndicatedanalytics.com
|
|
|
 |
A new report from IMARC Group entitled Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 finds that the market for HIV diagnostics is expected to grow exponentially in the coming years. Findings from the report suggest that although elisa based tests currently dominate this market, the popularity of rapid tests as a result of their ease of use and faster results is increasing rapidly in the country.
Apart from HIV, the report has also done a comprehensive analysis on the current and future potential of immunology based diagnostic tests for Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology. Metrics such as number of tests conducted each year, breakup by type of tests, current & future market sales, average cost of tests and the names key players has been provided for each indication in the report.
Key Questions Answered in this Report:
What is the current size and growth of the Indian Immunodiagnostics market?
What are the most popular types of Immunodiagnostic tests conducted in India?
What are the most popular indications for which Immunodiagnostic tests are conducted?
Who are the key players operating in the Indian Immunodiagnostics market?
What are the various regulations in the Indian Immunodiagnostics market?
What are the strengths, weaknesses, opportunities and threats in the Indian Immunodiagnostics Market?
What is the prevalence of Elisa and Rapid tests for each Indication?
What is the future of Immunodiagnostics in India?
What is the current and future landscape of HIV diagnostics in India?
What is the current and future landscape of Hepatitis B diagnostics in India?
What is the current and future landscape of Hepatitis C diagnostics in India?
What is the current and future landscape of Tuberculosis diagnostics in India?
What is the current and future landscape of Dengue diagnostics in India?
What is the current and future landscape of Syphilis diagnostics in India?
What is the current and future landscape of Cancer diagnostics in India?
Key Aspects Analyzed:
Diagnostic Antibodies
Understanding the strengths, weaknesses, opportunities and challenges in the Indian diagnostic antibodies market
Understanding the technological considerations and regulatory factors in the Indian diagnostic antibodies market
Evaluating the various types of antibody based diagnostic tests conducted in India and analyzing their strengths and weaknesses.
Understanding the key regulations for registering, manufacturing and importing diagnostics in India.
Comprehensive situation analysis of the Indian diagnostic antibodies market
Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology
Focus of the analysis in each segment:
Number of tests conducted each year
Breakup by type of tests conducted
Current and future market sales
Average cost of diagnostic tests
Key players operating in the market
Therapeutic Antibodies
Understanding the strengths, weaknesses, opportunities and challenges in the Indian therapeutic antibodies market
Understanding the technological considerations and regulatory factors in the Indian therapeutic antibodies market
Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act.
Understanding the key regulations for registering, manufacturing and importing therapeutic antibodies in India.
Evaluating the patent details of all globally marketed monoclonal antibodies in India, US and Europe
Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe.
Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not
Estimating the patent expiries of various monoclonal antibodies in India, US and Europe.
Comprehensive situation analysis of the Indian therapeutic antibodies market
Analyzing current and future sales of monoclonal antibodies in India
Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India
Analyzing the global and Indian monoclonal antibodies market by Indication
Evaluation of the top selling monoclonal antibodies
Key biosimilar antibody development programmes in India and abroad
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-425-6531
IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/indian-diagnostic-therapeutic-antibodies-market-report-forecast-2011-2016-2/
For more information, visit: http://www.imarcgroup.com
|
| Related Tags: Indian HIV Diagnostic Market, Indian antibodies market, Indian diagnostic market, Indian immunodiagnostics market, Indian immunology market |
Disclaimer
If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.
|
Business
![[Valid RSS]](images/valid-rss-rogers.png "Validate my RSS feed")
